产品编号 :
Cas No. :
CAS No. |
357-70-0 |
|---|---|
中文名称 |
(4aS,6R,8aS)-3-甲氧基-11-甲基-5,6,9,10,11,12-六氢-4aH-苯并[2,3]苯并呋喃并[4,3-cd]氮杂卓-6-醇 |
英文名称 |
(4aS,6R,8aS)-3-methoxy-11-methyl-4a,5,9,10,11,12-hexahydro-6H-benzo[2,3]benzofuro[4,3-cd]azepin-6-ol |
别名 |
AKOS015965330 | KBio3_002636 | Lycoremin | NSC-100058 | Spectrum5_001673 | KBioSS_001751 | BDBM10404 | Galantaminum | NCGC00017256-17 | NSC 100058 | Galantamine | DB00674 | AC-20240 | CHEBI:42944 | GALANTAMINE [VANDF] | Galantaminum [INN-Latin] | Jilkon | |
标准英文名 |
(4aS,6R,8aS)-3-methoxy-11-methyl-4a,5,9,10,11,12-hexahydro-6H-benzo[2,3]benzofuro[4,3-cd]azepin-6-ol |
MDL No. |
MFCD00867189 |
分子式 |
C17H21NO3 |
分子量 |
287.15 |
精确分子量 |
287.15 |
SMILES |
COC1=C2C3=C(C=C1)CN(C)CC[C@@]34[C@@](C[C@H](C=C4)O)([H])O2 |
标准SMILES |
COC1C=CC2CN(C)CC[C@@]34C=C[C@H](O)C[C@@H]3OC=1C4=2 |
用途 |
Galantamine is used for the treatment of myasthenia gravis, post-polio syndrome,小儿 paralysis sequelae, cerebral palsy in children, polyneuritis, radiculitis, and sensory or motor disorders caused by neurological diseases or trauma; it is also indicated for mild to moderate Alzheimer's disease. |
InChIKey |
ASUTZQLVASHGKV-JDFRZJQESA-N |
|
|
评论 |
|---|